PT - JOURNAL ARTICLE AU - Mo, Ziyi AU - Scheben, Armin AU - Steinberg, Joshua AU - Siepel, Adam AU - Martienssen, Robert TI - Circadian immunity, sunrise time and the seasonality of respiratory infections AID - 10.1101/2021.03.29.21254556 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.29.21254556 4099 - http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254556.short 4100 - http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254556.full AB - The innate and adaptive immune response are regulated by biological clocks, and circulating lymphocytes are lowest at sunrise. Accordingly, severity of disease in mouse models is highly dependent on the time of day of viral infection. Here, we explore whether circadian immunity contributes significantly to seasonality of respiratory viruses, including influenza and SARS-CoV-2. Susceptibility-Infection-Recovery-Susceptibility (SIRS) models of influenza and SIRS-derived models of COVID-19 suggest that local sunrise time is a better predictor of the basic reproductive number (R0) than climate, even when day length is taken into account. Moreover, these models predict a window of susceptibility when local sunrise time corresponds to the morning commute and contact rate is expected to be high. Counterfactual modeling suggests that retaining daylight savings time in the fall would reduce the length of this window, and substantially reduce seasonal waves of respiratory infections.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported, in part, by US National Institutes of Health grant R35-GM127070 (to A.S.), the Louis Morin Charitable Trust (J.S.), the Gladys & Roland Harriman Fellowship (Z.M.), the Howard Hughes Medical Institute (R.M.), and the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data used in this research are publicly accessible and therefore do not require IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code used in this study are publicly available (github.com/ziyimo/circ-immu). https://github.com/ziyimo/circ-immu